{
  "id": 1432,
  "text": "It should be noted that there was no significant trend for the analysis of DFS by stage.This meta-analysis described no evidence to suggest that the effect of chemoradiotherapy differed in groups of women defined by age, histology, tumour grade or whether they had PLN involvement.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: It should be noted that there was no significant trend for the analysis of DFS by stage.This meta-analysis described no evidence to suggest that the effect of chemoradiotherapy differed in groups of women defined by age, histology, tumour grade or whether they had PLN involvement.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据目前数据的分析，无病生存期（DFS）在分期之间未显示出显著的趋势。此外，化疗联合放疗（CRT）的效果并未因患者的年龄、组织学类型、肿瘤分级或是否存在盆腔淋巴结（PLN）受累而表现出明显的差异。这表明化疗联合放疗的疗效在不同患者群体中具有较为一致的表现。",
  "query": "根据您的请求，这段<text>与宫颈癌相关，因此我将生成一个问题：\n\n在分析宫颈癌患者的无病生存期（DFS）时，是否存在根据分期划分的显著趋势？化疗联合放疗的效果是否因患者的年龄、组织学类型、肿瘤分级或是否有盆腔淋巴结（PLN）受累而有所不同？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据您的请求，这段<text>与宫颈癌相关，因此我将生成一个问题：\n\n在分析宫颈癌患者的无病生存期（DFS）时，是否存在根据分期划分的显著趋势？化疗联合放疗的效果是否因患者的年龄、组织学类型、肿瘤分级或是否有盆腔淋巴结（PLN）受累而有所不同？\n\n<reference text>: It should be noted that there was no significant trend for the analysis of DFS by stage.This meta-analysis described no evidence to suggest that the effect of chemoradiotherapy differed in groups of women defined by age, histology, tumour grade or whether they had PLN involvement.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据目前数据的分析，无病生存期（DFS）在分期之间未显示出显著的趋势。此外，化疗联合放疗（CRT）的效果并未因患者的年龄、组织学类型、肿瘤分级或是否存在盆腔淋巴结（PLN）受累而表现出明显的差异。这表明化疗联合放疗的疗效在不同患者群体中具有较为一致的表现。"
}